Subtype
Digestive System Carcinoma
CI-CAN-00000812Explore in graph →
2,124 active trials27 approved drugs139 evidence items
- NCIt
- C96963
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000812Explore in graph →
Clinical trials
7,545 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (885)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02070822 | 3T MRI to Predict TACE Response of HCC | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Feb 25, 2014 | clinicaltrials |
| NCT02051283 | Pretreatment MRI Predicting Outcome After Radio-frequency Ablation of HCC | unknown | — | 200 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Jan 31, 2014 | clinicaltrials |
| NCT02036216 | Circulating Cell-free DNA as a Predictive Biomarker for Hepatocelluar Carcinoma. | unknown | — | 200 | Peking Union Medical College HospitalOTHER | 2 | Jan 14, 2014 | clinicaltrials |
| NCT02016274 | Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer | unknown | Phase 2 | 70 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT02016287 | Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer | unknown | Phase 2 | 50 | Shen LinOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT01997957 | A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC(SOON) | unknown | Phase 4 | 110 | Zhu XuOTHER | 1 | Nov 28, 2013 | clinicaltrials |
| NCT01993784 | Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. | unknown | Phase 1 / Phase 2 | 9 | Peking UniversityOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01930383 | Circulating Tumor Cells for Hepatocellular Carcinoma(CTCs for HCC) | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01962519 | Early Oral Feeding After Total Gastrectomy for Cancer | unknown | N/A | 112 | Jagiellonian UniversityOTHER | 1 | Oct 14, 2013 | clinicaltrials |
| NCT01957618 | The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy(CTEAM) | unknown | — | 1,500 | National Taiwan University HospitalOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT01942629 | Prognostic Value of the Marker P63 in Adenocarcinoma of Lung, Breast, and Pancreas | unknown | — | 300 | Rambam Health Care CampusOTHER | 0 | Sep 16, 2013 | clinicaltrials |
| NCT01937208 | Comparable Study of Different Radiation Dose in Esophageal Carcinoma | unknown | Phase 3 | 300 | Zhejiang Cancer HospitalOTHER | 1 | Sep 9, 2013 | clinicaltrials |
| NCT00562068 | Alemtuzumab and Combination Chemotherapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Peripheral T-Cell Lymphoma | unknown | Phase 1 | 30 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT00669812 | High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma | unknown | Phase 2 | 60 | Cancer Research UKOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01924624 | Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma | unknown | N/A | 140 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Aug 16, 2013 | clinicaltrials |
| NCT00445497 | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia | unknown | Phase 3 | 400 | Clatterbridge Centre for OncologyOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00963092 | Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer | unknown | — | 4,000 | Cancer Research UKOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01919151 | Micrometastasis in Gastrointestinal Cancer | unknown | — | 500 | Oslo University HospitalOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT01917370 | VEGF Signaling Promotes Cell Growth and Metastasis in Intrahepatic Cholangiocarcinoma in a VEGF Receptor Mediated Pathway(icc) | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Aug 6, 2013 | clinicaltrials |
| NCT01894269 | Chemoembolization With or Without Antiviral Therapy for Unresectable HBV-related HCC With Low HBV DNA Replication | unknown | Phase 4 | 200 | Sun Yat-sen UniversityOTHER | 1 | Jul 23, 2013 | clinicaltrials |
| NCT01892072 | VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway(HCC) | unknown | — | 50 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT01448668 | Iscador Qu as Supportive Treatment in Pancreatic Cancer (Union for International Cancer Control, UICC Stages II-IV) | unknown | — | 220 | IFAG AGINDUSTRY | 2 | Jul 2, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's HospitalOTHER | 0 | Jun 5, 2013 | clinicaltrials |
| NCT01283217 | Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer | unknown | Phase 3 | 166 | Yonsei UniversityOTHER | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01774266 | Detection of Methylated Reprimo in Plasma for Asymptomatic Gastric Cancer(DEMRAC) | unknown | — | 3,000 | Pontificia Universidad Catolica de ChileOTHER | 1 | Jun 3, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT01702116 | Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma | unknown | N/A | 34 | Stony Brook UniversityOTHER | 1 | Apr 25, 2013 | clinicaltrials |
| NCT01812876 | A Registry Study on Shenqifuzheng（a Chinese Medicine Injection）Used in Hospitals in China | unknown | — | 30,000 | China Academy of Chinese Medical SciencesOTHER | 0 | Apr 16, 2013 | clinicaltrials |
| NCT01833286 | TACE+RFA Versus Re-resection for Recurrent Small Hepatocellular Carcinoma(TACE-RFA) | unknown | Phase 3 | 200 | Sun Yat-sen UniversityOTHER | 1 | Apr 16, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT01811277 | SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Mar 15, 2013 | clinicaltrials |
| NCT01739465 | Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 120 | Guangzhou Medical UniversityOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT01668381 | Enumeration and Function Analysis of Treg Cells in Peripheral Blood of HCC Patients Before and After Ablation Therapy | unknown | — | 20 | First Affiliated Hospital, Sun Yat-Sen UniversityOTHER | 1 | Feb 21, 2013 | clinicaltrials |
| NCT01523015 | Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction | unknown | Phase 2 / Phase 3 | 100 | Medical University of LublinOTHER | 1 | Feb 5, 2013 | clinicaltrials |
| NCT01776346 | Barrett's Esophagus Patient Registry(BPR) | unknown | — | 750 | Massachusetts General HospitalOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT01764438 | Utility Study of Primovist-MRI on HCC Staging(PrimovistMRI) | unknown | — | 174 | Inha University HospitalOTHER | 1 | Jan 9, 2013 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT01227239 | Preoperative S-1/OHP With Radiation Therapy for Low-lying Rectal Carcinoma in Neo-adjuvant Setting | unknown | Phase 1 / Phase 2 | 45 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Nov 27, 2012 | clinicaltrials |
| NCT01621451 | Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD? | unknown | Phase 4 | 400 | Asan Medical CenterOTHER | 1 | Nov 22, 2012 | clinicaltrials |
| NCT01575717 | The Effect of Vitamin D Repletion in Patients With Hepatocellular Carcinoma on the Orthotopic Liver Transplant List | unknown | N/A | 50 | Andrea BranchOTHER | 1 | Oct 24, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT01688700 | Study of Nimotuzumab in Combination With Neoadjuvant Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma | unknown | Phase 2 | 60 | Zhejiang Cancer HospitalOTHER | 1 | Sep 20, 2012 | clinicaltrials |
| NCT01677468 | Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma | unknown | N/A | 250 | Hallym University Medical CenterOTHER | 1 | Sep 3, 2012 | clinicaltrials |
| NCT01659632 | Gastric Cancer Screening and Alarm Symptoms in Early Gastric Cancer | unknown | — | 1,000 | The Catholic University of KoreaOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT01573468 | Capecitabine/Tesetaxel Versus Capecitabine/Placebo as Second-line Therapy for Gastric Cancer(TESEGAST) | unknown | Phase 2 | 580 | Genta IncorporatedINDUSTRY | 3 | Jul 24, 2012 | clinicaltrials |
| NCT01442324 | Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma | unknown | N/A | 5 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2012 | clinicaltrials |
| NCT01549795 | Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy | unknown | N/A | 33 | Azienda Ospedaliera di PadovaOTHER | 1 | Jul 18, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Feb 25, 2014source: clinicaltrials